Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Sell
1
EHAB Quote, Financials, Valuation and Earnings
Last price:
$8.03
Seasonality move
:
-19.91%
Day range:
$7.66 - $8.28
52-week range:
$6.85 - $11.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.38x
P/B ratio:
0.75x
Volume:
303.5K
Avg. volume:
402.2K
1-year change:
-29.99%
Market cap:
$391.2M
Revenue:
$1B
EPS (TTM):
-$3.11
Analysts' Opinion
-
Consensus RatingEnhabit has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.00, Enhabit has an estimated upside of 16.13% from its current price of $7.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.50 representing 100% downside risk from its current price of $7.75.
Fair Value
-
According to the consensus of 5 analysts, Enhabit has 16.13% upside to fair value with a price target of $9.00 per share.
EHAB vs. S&P 500
-
Over the past 5 trading days, Enhabit has underperformed the S&P 500 by -3.74% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Enhabit does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Enhabit revenues have been falling on a year-over-year basis for 11 quarters in a row. In the most recent quarter Enhabit reported revenues of $258.2M.
Earnings Growth
-
Enhabit earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Enhabit reported earnings per share of -$0.92.
Enterprise value:
908.6M
EV / Invested capital:
--
Price / LTM sales:
0.38x
EV / EBIT:
26.09x
EV / Revenue:
0.88x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
19.17x
Price / Operating cash flow:
8.21x
Enterprise value / EBITDA:
14.22x
Gross Profit (TTM):
$504M
Return On Assets:
-11.44%
Net Income Margin (TTM):
-15.1%
Return On Equity:
-23.93%
Return On Invested Capital:
-13.14%
Operating Margin:
4.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1B | $1B | $260.6M | $258.2M | |
| Gross Profit | $545.5M | $510.7M | $504M | $127.1M | $125.1M | |
| Operating Income | $97.6M | $38.2M | $46.6M | $4.9M | $12.6M | |
| EBITDA | $22.5M | -$16.5M | -$83.6M | $12.6M | -$33.3M | |
| Diluted EPS | $1.25 | -$1.62 | -$3.11 | -$0.13 | -$0.92 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $178.8M | $211.8M | $210.1M | $192.7M | |
| Total Assets | -- | $1.7B | $1.5B | $1.4B | $1.2B | |
| Current Liabilities | -- | $136.5M | $132.9M | $137.7M | $126.2M | |
| Total Liabilities | -- | $236.7M | $751.5M | $731.9M | $672.1M | |
| Total Equity | -- | $1.5B | $775.3M | $701.7M | $553.9M | |
| Total Debt | -- | $8.5M | $583.1M | $552.6M | $515.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $80.1M | $48.4M | $51.2M | $2.9M | -$4.1M | |
| Cash From Investing | -$42.3M | -$5.3M | -$2.4M | $500K | -$300K | |
| Cash From Financing | -$18.6M | -$40.5M | -$48.3M | -$8.8M | -$12.7M | |
| Free Cash Flow | $73M | $44.9M | $47.4M | $3M | -$4.7M | |
EHAB
Sector
Market Cap
$391.2M
$33.1M
Price % of 52-Week High
68.28%
38.72%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.03%
1-Year Price Total Return
-29.99%
-49.46%
Beta (5-Year)
--
0.743
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.41
200-day SMA
Sell
Level
$8.24
Bollinger Bands (100)
Sell
Level
7.71 - 8.67
Chaikin Money Flow
Sell
Level
-1.2M
20-day SMA
Sell
Level
$8.71
Relative Strength Index (RSI14)
Sell
Level
32.50
ADX Line
Sell
Level
52.72
Williams %R
Buy
Level
-94.6746
50-day SMA
Sell
Level
$8.54
MACD (12, 26)
Buy
Level
1.96
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-2.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0628)
Sell
CA Score
(Annual)
Level (-0.7857)
Buy
Beneish M-Score
(Annual)
Level (-3.3875)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.2157)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Stock Forecast FAQ
In the current month, EHAB has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The EHAB average analyst price target in the past 3 months is $9.00.
-
Where Will Enhabit Stock Be In 1 Year?
According to analysts, the consensus estimate is that Enhabit share price will rise to $9.00 per share over the next 12 months.
-
What Do Analysts Say About Enhabit?
Analysts are divided on their view about Enhabit share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Enhabit is a Sell and believe this share price will drop from its current level to $8.50.
-
What Is Enhabit's Price Target?
The price target for Enhabit over the next 1-year time period is forecast to be $9.00 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is EHAB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Enhabit is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EHAB?
You can purchase shares of Enhabit via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Enhabit shares.
-
What Is The Enhabit Share Price Today?
Enhabit was last trading at $8.03 per share. This represents the most recent stock quote for Enhabit. Yesterday, Enhabit closed at $7.75 per share.
-
How To Buy Enhabit Stock Online?
In order to purchase Enhabit stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
How Bad Will the Stock Market Get?
In recent trading days, global stock markets have seen massive…
Stock Ideas
Sell
36
Is MSFT Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 30x
Sell
30
Is AAPL Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 28x
Sell
33
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 33x
Alerts
Sell
28
PRKS alert for Apr 9
United Parks & Resorts [PRKS] is up 15.37% over the past day.
Buy
55
SLNO alert for Apr 9
Soleno Therapeutics [SLNO] is up 7.3% over the past day.
Sell
20
HELE alert for Apr 9
Helen Of Troy [HELE] is up 10.1% over the past day.
